Skip to content
PLEASE DONATE Now To Help Get the THIRD Clinical Trial Going!
Addi_360_120_TM
  • About
  • Science
  • Clinical
  • News
  • Investors

News

Post Category Filter
  • All
  • Media Highlight (37)
  • Articles (11)
  • Publication (4)
  • Press Release (2)

Media Highlight

June 27, 2024

Jeff Galvin Explains AGT’s Innovative Approach to HIV on Bio Blast

Read More >

Media Highlight

June 5, 2024

Marcus Conant, MD, on More Research Needed With HIV Therapies

Read More >

Publication

May 14, 2024

Multiple Treatment Interruptions and Protecting HIV-Specific CD4 T Cells Enable Durable CD8 T Cell Response and Viral Control

Read More >

Media Highlight

May 10, 2024

A Lifetime Fighting HIV: Dr. Marcus Conant Shares Addimmune’s Vision for a Cell Therapy Cure

Read More >

Media Highlight

April 5, 2024

Addimmune’s Dr. Marcus Conant, MD on CGTLive Discusses Gene Therapy for HIV Suppression

Read More >

Media Highlight

April 2, 2024

Addimmune: Helping Power the Gene and Cell Therapy Revolution in Montgomery County

Read More >

Articles

March 5, 2024

Transaction Trends 2023: Things Are Starting to Look Up

Read More >

Media Highlight

February 27, 2024

Empowered Patient: The Potential of a Functional Cure for HIV with Dr. Marc Conant of Addimmune

Read More >

Featured Post

February 13, 2024

Bringing hope to those living with HIV: Addimmune’s promising potential treatment in development

Read More >
White Logo

9713 Key West Ave, 5th Floor
Rockville, MD 20850
(301) 337-2100

Company

About
Science
News
Investors
Careers
Privacy

Contacts

Press
Investors
General

Updates

© 2025 Addimmune. All Rights Reserved.